1. Home
  2. RYTM vs MSA Comparison

RYTM vs MSA Comparison

Compare RYTM & MSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • MSA
  • Stock Information
  • Founded
  • RYTM 2008
  • MSA 1914
  • Country
  • RYTM United States
  • MSA United States
  • Employees
  • RYTM N/A
  • MSA N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • MSA Industrial Specialties
  • Sector
  • RYTM Health Care
  • MSA Health Care
  • Exchange
  • RYTM Nasdaq
  • MSA Nasdaq
  • Market Cap
  • RYTM 5.9B
  • MSA 6.5B
  • IPO Year
  • RYTM 2017
  • MSA N/A
  • Fundamental
  • Price
  • RYTM $97.61
  • MSA $169.55
  • Analyst Decision
  • RYTM Strong Buy
  • MSA Buy
  • Analyst Count
  • RYTM 13
  • MSA 5
  • Target Price
  • RYTM $101.92
  • MSA $188.20
  • AVG Volume (30 Days)
  • RYTM 578.8K
  • MSA 235.0K
  • Earning Date
  • RYTM 08-05-2025
  • MSA 08-04-2025
  • Dividend Yield
  • RYTM N/A
  • MSA 1.25%
  • EPS Growth
  • RYTM N/A
  • MSA 2.08
  • EPS
  • RYTM N/A
  • MSA 7.01
  • Revenue
  • RYTM $156,287,000.00
  • MSA $1,827,831,000.00
  • Revenue This Year
  • RYTM $37.86
  • MSA $2.98
  • Revenue Next Year
  • RYTM $72.72
  • MSA $5.21
  • P/E Ratio
  • RYTM N/A
  • MSA $24.15
  • Revenue Growth
  • RYTM 53.55
  • MSA 0.55
  • 52 Week Low
  • RYTM $43.57
  • MSA $127.86
  • 52 Week High
  • RYTM $99.04
  • MSA $187.41
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 73.48
  • MSA 42.19
  • Support Level
  • RYTM $95.30
  • MSA $168.64
  • Resistance Level
  • RYTM $99.04
  • MSA $173.95
  • Average True Range (ATR)
  • RYTM 3.21
  • MSA 3.57
  • MACD
  • RYTM 0.20
  • MSA -1.24
  • Stochastic Oscillator
  • RYTM 90.50
  • MSA 12.00

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: